IDiyas

For the Inventor, By the Inventor

Westlake Village, CA, United States of America

Alexander J Pickrell

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 12.3

ph-index = 6

Forward Citations = 151(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2020 - 2022)
  • Westlake Village, CA (US) (2009 - 2024)

Company Filing History:

goldMedal28 out of 1,970 
 
Amgen Inc.
 patents

Years Active: 2009-2025

where 'Filed Patents' based on already Granted Patents

28 patents (USPTO):
1. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),
2. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),
3. 11807693 - Apelin polypeptides (2023-11-07),
4. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),
5. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),
6. 11285135 - KRAS G12C inhibitors and methods of using the same (2022-03-29),
7. 11224601 - Compounds that inhibits MCL-1 protein (2022-01-18),
8. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),
9. 10941182 - Apelin polypeptides (2021-03-09),
10. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use (2021-01-12),
11. 10821115 - Compounds that inhibit Mcl-1 protein (2020-11-03),
12. 10632128 - Compounds that inhibit Mcl-1 protein (2020-04-28),
13. 10532042 - KRAS G12C inhibitors and methods of using the same (2020-01-14),
14. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors (2017-08-01),
15. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),

Title: Unveiling the Innovations of Alexander J Pickrell

Introduction

Meet Alexander J Pickrell, a prolific inventor in the heart of Westlake Village, CA. With an impressive track record of 26 patents to his name, Pickrell is at the forefront of groundbreaking discoveries in the field of biotechnology and pharmaceuticals.

Latest Patents

Pickrell's recent patents showcase his ingenuity and dedication to advancing medical treatments. One notable invention is the development of Apelin polypeptides, which are modified to enhance stability, circulating half-life, and potency. These polypeptides offer promising solutions for treating cardiac disorders, particularly heart failure. Additionally, Pickrell has pioneered KRAS G12C inhibitors, a breakthrough in targeting pancreatic, colorectal, and lung cancers with precision and efficacy.

Career Highlights

Currently employed at Amgen Inc., Pickrell continues to push the boundaries of science and innovation. His contributions have significantly impacted the development of cutting-edge therapies that improve patient outcomes and quality of life. Pickrell's unwavering commitment to research and development underscores his passion for making a difference in the healthcare landscape.

Collaborations

In his pursuit of excellence, Pickrell has collaborated with esteemed professionals in the industry. Notably, his partnerships with Michael J Frohn and Jennifer Rebecca Allen have led to synergistic efforts in driving forward novel ideas and transformative solutions in healthcare. Through collaborative endeavors, Pickrell has cultivated a network of like-minded visionaries dedicated to advancing medical science.

Conclusion

Alexander J Pickrell's inventive spirit and relentless drive have solidified his position as a trailblazer in the realm of medical innovation. With a wealth of patents under his belt and a commitment to pushing the boundaries of possibility, Pickrell embodies the essence of a true visionary shaping the future of healthcare. As he continues to pioneer groundbreaking inventions, the impact of his work reverberates throughout the industry, offering hope and healing to those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…